Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy

NCT02795572 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Retirement of the Principal Investigator

Conditions

Peripheral Neuropathy in Breast Cancer Patient

Interventions

DIETARY_SUPPLEMENT: Vitamin D
DIETARY_SUPPLEMENT: Vitamin B6
DIETARY_SUPPLEMENT: Vitamin B12
DIETARY_SUPPLEMENT: Omega-3 Fatty Acids

Sponsor

AHS Cancer Control Alberta